MilliporeSigma
Search Within
Document Type

214-226-4

Applied Filters:
Keyword:'214-226-4'
Showing 1-30 of 50 results for "214-226-4" within Technical Documents
Data Sheet - SML0726
Biophys. Res. Commun., 226, 214-221 (1996). 3. Yamamoto, Y.,and Gaynor, R. B., IκB kinases: key regulators of the NF-κB pathway. Trends Biochem. Sci., 29, 72–79. (2004). 4. Cota, B. B., et al.
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Expected Range Units Cytokine QC Level Expected Range Units EGF Control 1 103 - 214 pg/mL IL-12 (p70) Control 1 109 - 226 pg/mL Control 2 536 - 1113 pg/mL
XP725 Antibody Number-Lot Number 071M4826
225 226 227 228 249 250 251 252 273 274 275 276 3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260
Product Information Sheet - F4274
T.E.W., Immunology, 18, 865-873 and 875-881 (1970). 6. Goding, J.W., J. Immunol. Methods, 13, 215-226 (1976). 7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June 1975). Standard test for labeling efficiency
Product Information Sheet - F7250
T.E.W., Immunology, 18, 865-873 and 875-881 (1970). 6. Goding, J.W., J. Immunol. Methods, 13, 215-226 (1976). 7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June 1975). Standard test for labeling efficiency
Product Information Sheet - F4002
T.E.W., Immunology, 18, 865-873 and 875-881 (1970). 6. Goding, J.W., J. Immunol. Methods, 13, 215-226 (1976). 7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June 1975). Standard test for labeling efficiency
Product Information Sheet - F3651
T.E.W., Immunology, 18, 865-873 and 875-881 (1970). 6. Goding, J.W., J. Immunol. Methods, 13, 215-226 (1976). 7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June 1975). Standard test for labeling efficiency
Sustained Release Tablets using PVA DC Formulation - Alcohol Dose-Dumping Under Control
formulations resistant to alcohol- induced dose dumping – A review. Eur. J. Pharm. Biopharm., 87, 217-226 (2014). Figure 1: Compressibility and ejection forces. Figure 2: Propranolol HCl release from
Product Information Sheet - CYTOCOX1
(1990). 4. Hovius, R., et al., Biochim. Biophys. Acta, 1021, 217-226 (1990). 5. Rasmussen, U.F., and Rasmussen, H.N., Mol. Cell. Biochem., 208, 37-44 (2000). 6. Musatov, A., et al., Biochem.
Data Sheet - 77237
et al., Life Sci., 54, 1403-1409 (1994). Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992). Thymocytes Hoshino. J. et al., Biochem. International, 27, 105-116 (1992).
Product Information Sheet - PP0500
., Biochem. Biophy. Res. Commun., 280, 1367-1371 (2001). 28. Gupta, M.N. et al., Proteins, 39, 226-234 (2000). 29. Gupta, M.N., Eur. J. Biochem., 203, 25-32 (1992). 30. Minotti, A.M. et al., Anal. Biochem
Product Information Sheet - P4937
N. et al., Life Sci., 54, 1403-1409 (1994). Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992). Thymocytes Hoshino. J. et al., Biochem. International, 27, 105-116 (1992). Fearnhead
Product Information Sheet - E0414
N. et al., Life Sci., 54, 1403-1409 (1994). Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992). Thymocytes Hoshino. J. et al., Biochem. International, 27, 105-116 (1992). Fearnhead
Product Information Sheet -  
al., Life Sci., 54, 1403-1409 (1994). Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992). Thymocytes Hoshino. J. et al., Biochem. International, 27, 105-116 (1992).
Product Information Sheet - P7828
N. et al., Life Sci., 54, 1403-1409 (1994). Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992). Thymocytes Hoshino. J. et al., Biochem. International, 27, 105-116 (1992). Fearnhead
Product Information Sheet - P1644
N. et al., Life Sci., 54, 1403-1409 (1994). Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992). Thymocytes Hoshino. J. et al., Biochem. International, 27, 105-116 (1992). Fearnhead
Calbiochem Biologics 29.2
512660 1 mg 5 mg Ref.: Kahns, S., et al. 2002. J. Biol. Chem. 277, 15303. US $ 212 226 226 212 $ 60 $ 240 To Order Call Customer Service at
Pellicon®3 Cassettes with Ultracel®Membrane Performance Guide
) Final Protein Concentration (g/L) Final Viscosity (cP) Yield (%) P3C030C01 C 24 226 54 103 P3C030D01 D 21 242 78 101 P2C030V01 V 10 277 230 102 Cleanability Pellicon® cassettes
Calbiochem Biologics 30.2
tissues and overexpressed in some cancers. IB, PS 50 µl 153 Cat. No. 444168 50 µl $214 Cat. No. 444169 50 µl $214 CORRECTIONS 11.10.04.indd Sec2:17CORRECTIONS 11.10.04.indd Sec2:17 11/10/04
User Guide Equinox SOP Software 2.1 for Windows XP
205 206 206 207 207 208 208 209 209 210 210 210 211 211 213 213 213 214 214 215 215 216 216 Contenido Capítulo 4. Exportar los procedimientos SOP a la bomba Steritest Equinox..........
Biologics 30.1
IB Anti-Cathepsin R, IM1002 Detects both the pro and mature forms of cathepsin R at ~50 100 µl 226 Mouse (Rabbit) and 32 kDa. IB, IP, PS Anti-Cathepsin S, IM1003 Detects the pro- and mature forms
Chrombook 2015 - The world of chromatography in your hands
% B to 50 % B in 20 min Flow rate 0.3 mL/min Detection UV 214 nm Sample 1 µL BSA digest (1mg/mL) 0 1 2 3 4 5 6 1 2 3 4 5
Inhibitor Sourcebook 3rd Edition
A 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No.569396) in DMSO is also available. 100 µg 250 µg TX-1123 655200 [2-((3,5-di-tert-Butyl-4-hydroxyphenyl)-methylene)-4-cyclopentene-1,3-
Perfection in every dimension 2014. Inorganic reagents Catalogue
glacial) 100 % for analysis EMPARTA® ACS 101830 110 Acetic acid (glacial) 100 % Suprapur® 100066 226 Acetic acid 1 mol/l prepared from raw materials acc. Ph Eur Titripur® 199061 142 Acetic acid
Mobius®Chrom 20 System User guide
................................... 226 Overview .............................................................................................................. 226 Archiving Intervals ...............
List of Antibodies
www.sigmaaldrich.com/ProductLookup.html?ProdNo=C5987&Brand=SIGMA� 186 COX II C9354 M y n/d n/d 226 Dnase II D1689 P y n/d n/d 149 Cdc14A C2238 M y n/d n/d 150 Cdc25c
XP725 Antibody List Lot 129K4830
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y 238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y 226 Dnase II D1689 1777 DNASE2 P NP_001366.1 y n/d n/d 227 DNMT1 D4567 1786 DNMT1 P NP_001124295.1 y y
XP725 Antibody List Lot 129K4831
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y 238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y 226 Dnase II D1689 1777 DNASE2 P NP_001366.1 y n/d n/d 227 DNMT1 D4567 1786 DNMT1 P NP_001124295.1 y y
XP725 Antibody List Lot 089K4791
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y 238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y 226 Dnase II D1689 1777 DNASE2 P NP_001366.1 y n/d n/d 227 DNMT1 D4567 1786 DNMT1 P NP_001124295.1 y y
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
MEK1 and MEK2 are activated by phosphorylation of two serine residues (Ser218/222 in MEK1 and Ser222/226 in MEK2), which are substrates for the Raf family of kinases. Mutation of the phosphorylation sites
Page 1 of 2